EAU 2022 | The importance of TURBT in bladder cancer management

Kevin Gallagher, MBChB, Western General Hospital, Edinburgh, UK discusses RESECT (NCT05154084), an observational study investigating the quality of transurethral resection of bladder tumour (TURBT) and its impact on the diagnosis and treatment of non-muscle-invasive bladder cancer (NMIBC). Moreover, Dr Gallagher emphasises how the quality of TURBT surgery relates to the accuracy of the initial staging, and how inaccuracies or delays in diagnosis at the time of TURBT can impact the timeliness of definitive treatment in muscle-invasive bladder cancer (MIBC), therefore affecting survivorship. This interview took place at the European Association of Urology (EAU) Meeting 2022.